AI-generated summary
The authors reviewed published human, animal, epidemiological and case studies on fractional infrared laser treatment as a way to prevent keratinocyte carcinoma and actinic keratosis. They report that ablative fractional lasers reduced and delayed these lesions in two controlled human trials and two mouse studies, while evidence for nonablative lasers rests on one retrospective cohort study. Evidence is limited in strength and the authors highlight it as most promising for secondary prevention in photodamaged people.
- Who or what was studied
- Photodamaged patients with actinic keratosis or keratinocyte carcinoma risk, plus murine models
- Limits stated in the abstract
- The evidence base is small, includes only two controlled human trials, two murine studies and one retrospective cohort, and the review does not report a pooled sample size.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.